12 Oct Charles River Laboratories
Ramin Baghirzade, Ph.D., Global Head Commercial, Gene Therapy CDMO Services
Oct. 12 | 2:00pm | Oxford Biomedica Ballroom
A CRO/CDMO with 75 years experience bringing therapeutics to market. Charles River now has a concept-to-commercial portfolio in cell and gene therapy enabling partners to reduce the number of complex external relationships which need to be managed. This serves to simplify the CRO/CDMO relationship and speed time to clinic and commercial.